Quick Overview: "ClC1=CC=C(C2=N[C@](CC(OC(C)(C)C)=O)C3=NN=C(C)N3C4=C2C(C)=C(C)S4)C=C1" Dr. Jay Bradner ... way that we've been approaching this development of drugs dana-farber which we call ... Foundation to examine whether this idea of

Fotd195 Open Source Drug Discovery - Detailed Overview & Context

"ClC1=CC=C(C2=N[C@](CC(OC(C)(C)C)=O)C3=NN=C(C)N3C4=C2C(C)=C(C)S4)C=C1" Dr. Jay Bradner ... way that we've been approaching this development of drugs dana-farber which we call ... Foundation to examine whether this idea of Google TechTalks April 07, 2006 ABSTRACT Marc works with an initiative that seeks to make biological and genomic data The story of the Open Source Drug Discovery project Dr. Paul Willis speaks at ISNTD d³ 2016 about

Dana-Farber researcher Haribabu Arthanari, PhD, briefly describes the A recent paper, 'A New Pharmaceutical Commons: Transforming

Photo Gallery

#FOTD195 Open Source Drug Discovery for Cancer Treatment
TEDxBoston - Dr Jay Bradner - Opensource Drug Discovery
Presidential Speaker Series: Open Source Drug Discovery
Dr. Matthew Todd - Six principles of open source drug discovery
Open Source Drug Discovery for Neglected Diseases
Open Source Drug Discovery for Neglected Diseases
The story of the Open Source Drug Discovery project
Dr. Paul Willis (MMV): Open source drug discovery & the MMV Pathogen Box
How does an open-source drug discovery platform empower clinicians? - with Dr. Sanjay Juneja
Is Open Source Drug Discovery Practical? (1/4)
Is Open Source Drug Discovery Practical? (3/4)
Malaria open source drug discovery design meeting 2016 05 24
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored